The aim of this study was to investigate in vitro the effects of pediocin A [a bacteriocin produced by lactic acid bacteria (LAB) Pediococcus pentosaceus FBB61] on microbial metabolism in the small and large intestine of pigs. Pediocin A was partially purified by ion exchange chromatography and added to an in vitro fermentation system. The intestinal inoculum was collected from pigs immediately after slaughter, diluted with a buffer, and dispensed into fermentation syringes and vessels of the 2 experimental groups: 1) Bac+ = cecal liquor + predigested diet + pediocin A (final concentration 160 activity units/mL); 2) Bac− = cecal liquor + predigested diet + partially purified supernatant of P. pentosaceus FBB61-2. Intestinal microbial growth was monitored using the cumulative gas production technique; the kinetics of fermentation, bacterial counts, VFA, ammonia, polyamines, and p-cresol production were analyzed. Pediocin A had almost no effects on small intestine fermentation parameters, whereas in the cecum pediocin A decreased gas production (−16%; P < 0.05), ammonia, and VFA production (−52 and −21%, respectively, after 24 h; P < 0.001) compared with the control group. Significant inhibition of clostridia and LAB occurred in cecal fermentations: the Bac+ group yielded a decreased number of clostridia and LAB in cecal fermentations (8.19 and 7.80 cfu/mL, respectively) compared with Bac− (9.32 and 8.95 cfu/mL, respectively; P < 0.001). The low clostridia counts in the pediocin-treated group may also explain the reduced concentration of the carcinogenic compound p-cresol (−88%; P < 0.01). Our results suggest that pediocin A could be an alternative to replace antibiotic growth promoters for the prophylaxis of enteric diseases and to improve production of farm animals.
INTRODUCTION
At weaning, stressful events such as regrouping and dietary shifting often compromise the intestinal microbial balance, resulting in low performance, disease, and even death. The addition of antibiotics to animal feeds has been practiced for over 40 yr to prevent weaningrelated production issues and has been well established in poultry (Stokstad and Jukes, 1949) , swine (Jukes et al., 1950) , and ruminants (Jukes and Williams, 1953) . However, the use of antibiotics as therapeutics or growth promoters leads to a high selection pressure, resulting in resistant strains of pathogenic bacteria that may infect humans and animals (e.g., Salmonella spp. and Escherichia coli). Based on these concerns, the Swann Committee (1969) concluded that antibiotics used in human chemotherapy and those that might promote cross-resistance in human pathogens should not be used as growth promoters (Butaye et al., 2003) . A promising approach to overcome the antibiotic growth promoters (AGP) crisis comes from bacterial antimicrobial peptides, termed bacteriocins, produced by almost all known bacteria (Klaenhammer, 1988) . Bacteriocins produced by lactic acid bacteria (LAB) seem to be the most potential candidates as new natural "gut-helpers" to replace AGP, because certain strains of LAB are GRAS (generally recognized as safe) and are considered safe under the conditions of their intended use (Montville and Winkowski, 1997) .
At present, nisin is the only bacteriocin approved as a food additive over the past few decades. Moreover, Callaway et al. (1997) showed that nisin might be a substitute for the ionophore monensin in controlling ruminal fermentations. Pediocin A, the bacteriocin produced by Pediococcus pentosaceus FBB61 is a po-tent antimicrobial against a broad spectrum of grampositive bacteria, and was here studied, using a swine in vitro intestinal fermentation system, for efficacy in preserving gut health by controlling intestinal microflora metabolism.
MATERIALS AND METHODS
The study was approved by the ethical committee of the University of Bologna.
Bacterial Strains and Media
Pediococcus pentosaceus FBB61 (ATCC 43200) and Pediococcus pentosaceus FBB61-2 were cultured at 39°C in M17 broth + 1% (wt/vol) glucose (Oxoid, Basingstoke, United Kingdom; Sambrook et al., 1989) . Pediococcus pentosaceus FBB61-2 (Bac−, Imm−) is the isogenic mutant of P. pentosaceus FBB61 (Bac+, Imm+) lacking the plasmid pMD136, which confers the immunity (Imm) and bacteriocin production (Bac) phenotypes (Daeschel and Klaenhammer, 1985; Piva et al., 1995) . Clostridia were enumerated using Tryptone Sulphite Cycloserine agar (Oxoid, Basingstoke, United Kingdom), coliforms with Sorbitol McConkey agar (Oxoid, Basingstoke, United Kingdom), and LAB with Rogosa agar (Oxoid, Basingstoke, United Kingdom).
Pediocin A Production and Partial Purification
Pediococcus pentosaceus FBB61 and P. pentosaceus FBB61-2 were cultured in M17 + 1% glucose at 39°C for 24 h. The culture supernatants were separately collected, filtered through 0.45-µm pore-size filters (Millipore SpA, Vimodrone, Milano, Italy), concentrated by polyethylene glycol dialysis (PEG 20,000, SigmaAldrich, St. Louis, MO), again filter-sterilized, and frozen at -20°C when not used immediately. This material from P. pentosaceus FBB61 was designated as crude pediocin A. Partial purification of pediocin A was achieved by ion exchange chromatography (HiTrap Q, 5 mL, Pharmacia Biotech, GE Healthcare Europe GmbH, Milano, Italy), according to the manufacturer guidelines. Proteins were separated by step-wise elution using NaCl solutions with increasing ionic strength. Eluted fractions were dialyzed against sterile distilled water to eliminate excess of NaCl, and 20-µL aliquots were serially diluted 2-fold and dispensed into wells in an M17 agar plate previously seeded with P. pentosaceus FBB61-2 and incubated at 39°C overnight to titer pediocin A content. Pediocin A concentration was measured in activity units per milliliter (AU/mL) and was defined as the reciprocal of the greatest dilution showing clear growth inhibition of the indicator P. pentosaceus FBB61-2. Total protein concentration was measured spectrophotometrically (Ultrospec 3000, Pharmacia Biotech, GE Healthcare Europe GmbH) at 600 nm wavelength according to Peterson's modification of the micro-Lowry method (Peterson, 1977) .
In Vitro Intestinal Fermentations
A standard diet for pigs was digested as described by Vervaeke et al. (1989) and used in the in vitro fermentations performed in a batch culture system as described by Piva et al. (1996b) . Briefly, cecal contents collected from 6 pigs immediately after slaughter were pooled, filtered and diluted (1:3, vol/vol) with McDougall buffer (McDougall, 1948) and dispensed into each fermentation vessel (n = 3) of the 2 experimental groups: 1) Bac+ = cecal liquor (15 mL) + 20 mg of predigested feed + pediocin A (final concentration 160 AU/mL); 2) Bac− = cecal liquor (15 mL) + 20 mg of predigested feed + partially purified supernatant of P. pentosaceus FBB61-2. Group Bac− was considered as an internal control differing from Bac+ only for the absence of pediocin A. Small intestine fermentations were executed with the same experimental design with the following differences: intestinal contents were diluted 1:10 (vol/ vol) in McDougall buffer, and 15 mL was dispensed per fermentation vessel containing 60 mg of predigested diet. Pediocin concentration in small intestine fermentation was the same as in the cecal experiment. Fermentation vessels were incubated in a shaking waterbath at 39°C and sampled for p-cresol, mono-, di-, and polyamines analyses at 8, 16, 31, and 48 h; ammonia production was determined at 4, 8, and 24 h; clostridia, coliforms, and LAB counts were determined by dilution and plating at 8 and 24 h. Total gas production was measured every 30 min as described by Menke et al. (1979) , whereas VFA concentrations were analyzed at 24 h.
Chemical Analyses of Cecal Fermentation Samples
Samples were analyzed for p-cresol content as described by Birkett et al. (1995) . Polyamines were separated and quantified by HPLC with fluorimetric detection as follows: frozen samples were thawed on ice, homogenized with 10 mL of 0.2 mol/L of perchloric acid in presence of 1,7-diaminoheptane (16 nmol/L final concentration) as internal standard, left 1 h at 4°C, rehomogenized, and centrifuged at 9,000 × g for 20 min at 4°C. Amines were derivatized according to the methods of Galston (1985) . High-performance liquid chromatography was performed with a system consisting of 2 solvent metering pumps (PU-980, JASCO Europe Srl, Lecco, Italy) and an auto sampler (AS-950, JASCO Europe Srl). Samples were injected into a fixed 100-µL loop for loading onto a reverse phase C18 column (LiChroCART 125-4, Superspher 100, RP-18, Merck KgaA, Darmstadt, Germany). Samples were eluted from the column with a programmed water:acetonitrile (vol/vol) solvent gradient, changing from 40 to 70% during 17 min at a flow rate of 1 mL/min. Elution was completed within 26 min. Elutes from the column were detected by an attached fluorescence spectrophotometer (FP-920, JASCO Europe Srl), using an excitation wavelength of 340 nm and an emission wavelength of 545 nm (Seiler and Knodgen, 1978) . Volatile fatty acids were analyzed by gas chromatography (Varian 3400, Varian Analytical Instruments, Palo Alto, CA; Carbopack B-DA/4% CW 2M, 80/120, packed column; Supelco, Sigma-Aldrich). Before injection, intestinal content was centrifuged (6,000 × g, 15 min, 4°C) and 2 mL of the supernatant was added to 1 mL of pivalic acid (98% pure), 1 mL of ossalic acid (99.8% pure), and 250 µL of formic acid (99% pure; Fussel and McCailey, 1987) . Ammonia content was analyzed as described by Searcy et al. (1967) .
Modeling and Statistics
The Gompertz bacterial growth model was used to fit gas production data, assuming that the substrate level limits growth in a logarithmic relationship (Schofield et al., 1994) . The Gompertz equation for gas production is as follows:
where symbols have the meaning assigned by Zwietering et al. (1990) : V = volume of gas produced at time T, T = fermentation time, V F = maximum volume of gas produced, µ m = maximum rate of gas production, which occurs at the point of inflection of the gas curve; and λ = the lag time, as the time-axis intercept of a tangent line at the point of inflection. The duration of the exponential phase was calculated from the parameters of the modified Gompertz equation, as suggested by Zwietering et al. (1992) using the following equation:
The experiment was conducted using 4 replicates for the small intestine fermentation, and 3 replicates for the cecal fermentation. Ammonia, VFA, and bacterial counts data were compared with an unpaired t-Student, and means were considered statistically significant at P < 0.05. Graphpad Prism 4.0 (GraphPad Software, San Diego, CA) was used for curve fitting and all statistical analysis.
RESULTS

Production and Partial Purification of Pediocin A
Three productions and partial purifications were performed to collect a usable amount of pediocin A. The first partial purification led to the recovery of 35% of the activity present in the culture supernatant, indicating that the ion exchange chromatography is a more efficient purification method than the previously described butanol extraction (Piva and Headon, 1994) . Pediocin A was efficiently concentrated in only 1 elution fraction (500 mmol/L of NaCl ionic strength) characterized by a total protein content of 87.77 mg (0.48% of the total culture supernatant, 18,122.10 mg). Activity to protein content ratio was 743.75 AU/mg (Table 1) . Pediocin A recovery was sufficient to perform in vitro cecal fermentation experiments. The other 2 purification cycles were performed to scale-up pediocin A recovery, and the respective eluted fractions were pooled, freeze-dried, and re-suspended in sterile distilled water, increasing pediocin A concentration to 3,011 AU/mL. This product was used in the small intestine fermentation experiment.
In Vitro Fermentations: Gas Production
Pediocin A (Bac+) had no significant effect on total gas production in small intestine fermentations, whereas it decreased the gas production rate, 1.58 vs. 1.39 mL/h (P < 0.05). The duration of the exponential phase tended to be less pronounced within the Bac+ Ionic strength of the eluting solution (expressed as mmol/L of NaCl).
group, being 22% shorter than in Bac− (P = 0.06). Interestingly, data from cecal fermentations showed differences for all the variables recorded: V F was less (16%) in Bac+ (P < 0.05) and maximal gas production rate was slower (µ m , Bac+/µ m , Bac− = 0.5) compared with Bac−. Lag-time and duration of the exponential phase after pediocin A supplementation were greater by 605 and 71% than Bac− values, respectively (P < 0.01; Figure 1 ).
In Vitro Fermentations: Ammonia Production
Ammonia production was recorded at 4, 8, and 24 h of fermentation (Table 2) . No significant difference between Bac+ and Bac− groups was recorded during the small intestine fermentation (Table 2 ). In cecal fermentations, NH 3 concentration was lower (P < 0.001) for Bac+ compared with Bac−: −27% at 4 h, −32% at 8 h, and -52% at the fermentation endpoint. The linear regression between concentration and time of fermentation (R 2 Bac+ = 0.823; R 2 Bac− = 0.964) resulted in less hourly production rate in Bac+ (1.36 mmol/L/h) than Bac− (3.33 mmol/L/h) group (P < 0.001).
In Vitro Fermentations: VFA Production
Fermentation vessels were sampled for VFA after 24 h of incubation. In vitro small intestine fermentations resulted in no effect of pediocin A on VFA production. Only 2 iso-acids (iso-butyric and iso-valeric) tended to be less (P = 0.08 and P = 0.11, respectively) in Bac+ treatment. Data from cecal fermentations revealed interesting effects compared with those from small intestine, caused by pediocin A (Table 3) . At a concentration of 160 AU/mL, pediocin A-containing vessels had reduced total VFA concentration (−21%; P < 0.001) compared with the Bac− group, in accordance with the decreased volume of gas produced. Individual VFA concentrations showed statistically significant differences between Bac+ and Bac−; iso-butyric acid reached 10 vs. 5% of total VFA production; nor-butyric acid was less (7.6 and 20% for Bac+ and Bac−, respectively, P = 0.02); iso-valeric acid production was reduced to 0.56% of all VFA in Bac+, whereas it reached 2.7% in Bac− vessels.
In Vitro Fermentations: Bacterial Counts
In vitro small intestine and cecal vessels were sampled at 8 and 24 h for bacterial counts. In both fermentations pediocin A showed antimicrobial properties against gram-positive bacteria (Table 4 ). In small intestine vessels, Bac+ reduced viable clostridia after 8 h of fermentation when compared with Bac− vessels (−1 Log; P < 0.001). This difference diminished to −0.3 Log after 24 h (P < 0.05). Lactic acid bacteria were affected only at the beginning of fermentation (−0.4 Log, P = 0.01), whereas no difference between Bac+ and Bac− groups was recorded at 24 h. Interestingly, coliforms, which were not expected to be pediocin A targets, were reduced (−0.7 Log vs. Bac−) after 24 h of fermentation in Bac+ vessels (P < 0.001). The Bac+ group also yielded a reduced number of clostridia and LAB in cecal fermentations (8.19 and 7.80 Log cfu/mL, respectively) compared with Bac− (9.32 and 8.95 Log cfu/mL, respectively; P < 0.001), whereas coliforms were not affected by treatment.
In Vitro Cecal Fermentation: Cresol, Mono-, Di-, and Poly-Amines
Only cecal fermentation vessels were sampled for cresol and amines analyses, as in vivo production of these compounds is not significant in the small intestine (Piva et al., 2002) . Comparison between Bac+ and Bac− values after 48 h of fermentation revealed a reduction of cresol production (−88%; P < 0.01; Figure  2 ). Pediocin A increased putrescine molar concentration from the beginning (4 h, 203% of Bac− P < 0.001) to the end of the experiment, reaching a plateau (~120 µmol/L) after 16 h of fermentation. Spermidine concentration was greater in Bac+ than in Bac− throughout the entire fermentation process. Interestingly, after initial shoot-up and plateau phases, spermidine concentration decreased from 37.58 to 8.08 µmol/L. Final spermidine concentration recorded in Bac− vessels was 1.74 µmol/L. Spermine, which is not produced/ metabolized by intestinal bacteria, was not affected by treatments (Figure 2 ).
DISCUSSION
Antimicrobial proteins and peptides, termed bacteriocins, are acknowledged as important weapons bacteria use to survive and dominate in ecosystems such as food supplies (De Vuyst and Leroy, 2007) . The aim of this research was to study the effects of pediocin A, produced by P. pentosaceus FBB61, on intestinal microbial metabolism, to collect more data supporting its possible future use as a "gut-helper" able to replace AGP.
Pediococcus pentosaceus FBB61 was originally isolated in 1953 from cucumber fermentations (Costilow et al., 1956 ). Subsequent observations (Galston, 1985; Fussel and McCailey, 1987; Montville and Winkowski, 1997) described its inhibitory activity against several strains of Listeria, Clostridium, Staphylococcus, and correlated it to pediocin A production. Okereke and Montville (1991) defined P. pentosaceus FBB61 as "the most promising strain to counteract the risk associated with C. botulinum contaminations in food." Because of its high molecular weight and sensitivity to degrading enzymes and temperature, pediocin A purification and concentration in amounts suitable for practical applications has been a difficult goal so far (Piva and Headon, 1994) . Our ion-exchange chromatography resulted in an appreciable amount of highly purified pediocin A, thus achieving a significantly better efficiency than previous methods based on butanol extraction (Piva and Headon, 1994) . The present in vitro fermentation experiments addressed the modulatory properties of pediocin A on microbial metabolism in the small and large intestine. The small intestine fermentation kinetic, represented by in vitro gas production, was not affected by pediocin A treatment. The small intestine is characterized by a rapid transit time and relatively limited bacterial populations, which do not have enough time to efficiently ferment carbon sources. Instead, the host has the opportunity to absorb the majority of the available nutrients at this site across the enormous intestinal absorptive surface area. At the same time, the jejunum and ileum are nutrient-rich environments, which can become the preferential site of pathogen overgrowth during enteritis, especially in stressful periods (e.g., weaning) when digestive and immune functions are impaired. We showed that pediocin A significantly reduced more harmful bacterial growth (clostridia and coliforms) compared with Bac−. Interestingly, whereas killing of gram-positive bacteria such as clostridia was an expected scenario, gram-negative bacteria, such as coliforms, were not known to be targeted directly by pediocin A. The decreased coliform population scored in the Bac+ group after 24 h of fermentation could be explained by environmental changes in the intestinal content, which could be harmful, or at least hostile to these gram-negative bacteria. Lactic acid bacteria are expected to be more susceptible to pediocin A because of their phylogenetic proximity to the producer strain P. pentosaceus FBB61. Lactic acid bacteria number decreased over the first 8 h of fermentation, showing an acute killing effect of pediocin A, but the population recovered by 24 h; this may suggest a selection for resistant LAB, although the mechanism for resistance to pediocin A has yet to be described. This reveals Means within a column and fermentation with differing superscripts differ, P < 0.05.
1 Bac+ = pediocin A added at 160 activity units/mL final concentration.
an intriguing possibility that pediocin A may beneficially modulate bacterial balance by favoring beneficial LAB presence at the site where noxious bacterial overgrowth occurs during enteritis. In vitro cecal fermentations rendered a more complex picture. This segment of the intestine is a highly populated environment (10 10 to 10 12 cfu/g of wet content; Moore et al., 1987; Butine and Leedle, 1989 ) mostly colonized by grampositive anaerobes (clostridia, eubacteria, streptococci, lactobacilli; Salanitro et al., 1977; Russell, 1979) , all of which are sensitive to pediocin A killing activity as dramatically shown by total gas production and bacterial counts data.
In the hindgut, structural carbohydrates, which are nondigestible in the nonruminant stomach and small intestine, are fermented by the microflora to produce large quantities of VFA readily absorbed by the colonic mucosa. As previously reported, VFA play a key role as energy sources, with butyric acid being the most quickly oxidized to CO 2 (Fleming and Gill, 1997) . Low molar proportion of iso-valeric acid revealed reduced deamination and decarboxylation of leucine, supporting the decreased proteolysis shown by the ammonia production data. Whereas acetic and propionic acid concentrations were not different, the acetic to propionic acid molar ratio tended to be greater in Bac+ vessels, suggesting a greater metabolism of cellulolytic bacteria. Gas production variables were recorded as indicative of intestinal microbial energetic metabolism (Menke et al., 1979; Piva et al., 1996a) . Data showed that pediocin A is able to reduce the extent of fermentation, resulting in a long-lasting utilization of energy sources. This also explains the reduced ammonia production observed. Indeed, bacterial enzymes appear to produce as much as 75% of alimentary tract ammonia (Visek, 1984) , which can destroy intestinal cells, alter nucleic acid synthesis, increase viral infections, favor growth of cancerous over noncancerous cells in tissue culture (Visek, 1978) , and cause reduced villi height (Nousiainen, 1991) . Furthermore, absorbed ammonia must be excreted as urea at an energy cost of approximately 7% of the total energy expenditure in nonruminant and ruminant animals (Eisemann and Nienaber, 1990) . Increased plasma concentrations of ammonia may inhibit insulin release, impairing glucose metabolism and animal performance (Visek, 1984) . Because energy is the limiting factor for microbial metabolism in the large intestine (Orskov et al., 1970) , as soon as bacteria utilize all pools of readily fermentable starches and carbohydrates, fermentations become more and more proteolytic, resulting in the overproduction of ammonia and noxious amines (Russell et al., 1983) . The beneficial effect of pediocin A on protein utilization by intestinal microflora was also shown by the significant reduction of p-cresol production. p-Cresol, a tyrosine metabolite, is considered to be a promoter of skin and liver cancer in mice (Boutwell and Bosch, 1959; Bakke and Midtvedt, 1970) , whereas in pigs it depresses growth (Yokoyama et al., 1982) . Pediocin A significantly increased cecal concen- Means within a column and fermentation with differing superscripts differ, P < 0.05.
2 Bac− = control, no pediocin A added.
Pediocin A controls gut microflora metabolism trations of the bioactive amines putrescine (+103%; P < 0.001) and spermidine (+34%; P < 0.05) that are considered to be essential for in vivo cell growth and proliferation. Bardocz et al. (1998) suggested that most of the polyamines necessary for cell proliferation in Lieberkuhn's crypts come from the body pool that is constantly replenished by amines originating from food and bacterial flora metabolism. Moreover, putrescine is always found in abundance at the top of intestinal villi, and can be used as an instant energy source when Means within a column and fermentation with differing superscripts differ, P < 0.05. Means with different letters differ (P < 0.05). nutrients are limited or there is a need to kick-start enterocyte growth. Although the in vitro fermentation model used in these experiments does not exactly mimic what occurs in the gut of animals, it can be used as a tool to study intestinal metabolism under specific conditions and to predict in vivo metabolic trends.
In conclusion, pediocin A was able to directly decrease clostridia and indirectly coliform counts, whereas the VFA pattern may suggest an increased metabolic activity of cellulolytic bacteria. Pediocin A could also mitigate the extent of cecal fermentations resulting in reduced proteolytic metabolism, as shown by decreased ammonia concentration. Furthermore, the selective action of pediocin A on certain, but not all, microbial species controlled individual AA metabolism (as occurred for tyrosine) with reduction of noxious secondary metabolites (p-cresol) and desirable polyamines (e. g., putrescine).
Clearly, pediocin A is able to control in vitro intestinal microbial metabolism and appears to be a promising new candidate to replace AGP in animal feeds, even though more studies are needed to validate these results in vivo. Furthermore, new research may also address novel and more effective methods of production and purification because pure pediocin A is needed to elucidate its mechanism of action.
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